Global epidemiology of hepatitis C virus infection.

By C. Shepard, L. Finelli, M. Alter. Lancet. Infectious Diseases (Print), 2005

3,054 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/641842a845c9a210dd7260609963f0013b3e79c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. G. Dusheiko
2. Alan D. Lopez
3. X. Forns
4. Christoph Sarrazin
5. J. Pawlotsky
6. M. Puoti
7. A. Aghemo
8. D. Lavanchy

In Hepatology

1. G. Dusheiko
2. Alan D. Lopez
3. X. Forns
4. Christoph Sarrazin
5. J. Pawlotsky
6. A. Aghemo
7. M. Puoti
8. D. Lavanchy

Citations in the corpus

• Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis (2014, background): “By contrast, preventive measures such as screening transfused blood for viral hepatitis, employing appropriate medical hygiene in health facilities, introducing hepatitis B vaccination programs, imposing alcohol trade restrictions and raising taxes on alcohol, implementing health promotion and educa”
• EASL Recommendations on Treatment of Hepatitis C 2016. (2017, background): “The prevalence of HCV among PWIDs is ~65% [80-82] and >80% among long-term PWIDs [80].”
• EASL Recommendations on Treatment of Hepatitis C 2018. (2018, background): “The prevalence of HCV among PWIDs is ~65% [80-82] and >80% among long-term PWIDs [80].”
• Evolving epidemiology of hepatitis C virus. (2011, background): “As measurement of incidence fails to produce reliable numbers, because of the mostly asymptomatic form of acute infection, most approximations are based on reviews of published prevalence data, which estimated that 130–170 million persons, or 2–3% of the world’s population, are infected with HCV [25”
• EASL Clinical Practice Guidelines: management of hepatitis C virus infection. (2011, background): “3% of the world population, are chronically infected with HCV [1,2].”
• Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. (2016, neutral): “East Asia 653,900 4% (2-7%) 28,800 (12,40045,100) 166,100 20% 96% 159,500 820,000 188,300 (171,900204,600) 8%”
• The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. (2006, background): “Other key primary prevention strategies include screening blood donors and maintaining infection control practices to prevent the transmission of healthcare-related HBV and HCV infections [105,109,110].”